CNSP icon

CNS Pharmaceuticals
CNSP

Overview Fund Trends Analyst Outlook Journalist POV

1 hedge funds and large institutions have $335K invested in CNS Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$320K

Top Sellers

1
-$81K
2
-$36K
3
-$23K
4
VF
Virtu Financial
New York
-$23K
5
TSS
Two Sigma Securities
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$320K
2
$11K
3
$2.91K
4
$1.16K
5
$82
6
$60
7
$20
8
$17
9
$2
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–